Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis

BACKGROUND AND AIMS: Tyrosine kinase 2 [TYK2] is required for the signalling of key cytokines in the pathogenesis of inflammatory bowel disease [IBD]. We assessed the efficacy of a novel selective TYK2 inhibitor [TYK2i] in experimental colitis, using pharmacological and genetic tools. METHODS: At on...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vries, Leonie C S, Ghiboub, Mohammed, van Hamersveld, Patricia H P, Welting, Olaf, Verseijden, Caroline, Bell, Matthew J, Rioja, Inmaculada, Prinjha, Rabinder K, Koelink, Pim J, Strobl, Birgit, Müller, Mathias, D’Haens, Geert R, Wildenberg, Manon E, De Jonge, Wouter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023831/
https://www.ncbi.nlm.nih.gov/pubmed/33005945
http://dx.doi.org/10.1093/ecco-jcc/jjaa199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023831/
https://www.ncbi.nlm.nih.gov/pubmed/33005945
http://dx.doi.org/10.1093/ecco-jcc/jjaa199

Ejemplares similares